Full text
Earnings transcript
Read the complete earnings call transcript.
VEEV
Veeva Systems Inc.
$262.4
1.42
(0.54%)
| Exchange: | NYSE |
| Market Cap: | 42.625B |
| Shares Outstanding: | 105.887M |
Delayed data
About The Company
| Sector: | TechnologyView sector performance | |||||
| Industry: | Software – ApplicationView industry performance | |||||
| CEO: | Peter Gassner | |||||
| Full Time Employees: | 7928 | |||||
| Address: |
| |||||
| Website: | https://www.veeva.com |
Veeva Systems Inc. is a leading provider of cloud-based software solutions, exclusively dedicated to the global life sciences industry. Its extensive operational presence spans across North America, Europe, the Asia Pacific region, the Middle East, Africa, and Latin America. The company’s product portfolio is primarily structured around two major offerings. First, the Veeva Commercial Cloud delivers an integrated suite of software, data, and analytics tools designed to optimize commercial operations. This includes vital applications such as Veeva Customer Relationship Management (CRM) and its specialized Medical CRM, Veeva Closed Loop Marketing (CLM), sophisticated analytics via Veeva CRM MyInsights, approved email communication with Veeva CRM Approved Email, digital engagement tools like Veeva CRM Engage, commercial alignment through Veeva Align, event management capabilities with Veeva CRM Events Management, data warehousing solutions (Veeva Nitro), data services (Veeva OpenData, Veeva Link), master data management (Veeva Network), advanced analytical insights (Veeva Crossix, Veeva Data Cloud), and patient engagement platforms (MyVeeva for Patients). Secondly, Veeva Vault provides a robust collection of cloud-native enterprise content and data management applications. These applications are engineered to support both critical commercial functions—encompassing sales, marketing, and medical content and communications—and comprehensive research and development processes, including clinical trials, regulatory compliance, quality management, and patient safety. Beyond its software, Veeva offers a wide array of professional and support services. These range from strategic implementation and deployment planning, project management, and detailed requirements analysis to solution design and configuration. They also include system environment management and deployment, expert consulting for business process transformation related to Veeva solutions, technical guidance on data migration and systems integrations, comprehensive training programs, and ongoing managed services such as outsourced systems administration. Tracing its origins, the company was incorporated in 2007 as Verticals onDemand, Inc., and subsequently rebranded to Veeva Systems Inc. in April 2009. Its corporate headquarters are situated in Pleasanton, California.
Click to read more…
Revenue Segmentation
EPS
Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.
Earnings Call
AI summary
Key takeaways
Short, structured highlights from the call so you can focus on what matters.
Log in to continue
Log in to read the full transcript and AI-generated earnings summaries.
Login — it's freeIncome Statement
| Year | 2024 | 2025 | 2026 |
|---|---|---|---|
| Revenue | 2,363,673 | 2,746,619 | 3,195,311 |
| Gross Profit | 1,686,382 | 2,046,983 | 2,413,292 |
| EBITDA | 620,651 | 958,764 | 1,244,979 |
| Operating Income | 429,334 | 691,435 | 916,369 |
| Net Income | 525,705 | 714,138 | 908,906 |
(* All numbers are in thousands)
Balance Sheet
| Year | 2024 | 2025 | 2026 |
|---|---|---|---|
| Total Assets | 5,910,920 | 7,339,756 | 8,979,343 |
| Total Liabilities | 1,266,096 | 1,507,383 | 1,764,591 |
| Total Stockholders Equity | 4,644,824 | 5,832,373 | 7,214,752 |
| Total Debt | 55,775 | 75,775 | 95,859 |
| Cash and Cash Equivalents | 703,487 | 1,118,785 | 1,421,233 |
(* All numbers are in thousands)
Cash Flow Statement
| Year | 2024 | 2025 | 2026 |
|---|---|---|---|
| Operating Cash Flow | 911,339 | 1,090,051 | 1,415,225 |
| Capital Expenditure | -26,196 | 0 | 0 |
| Free Cash Flow | 885,143 | 1,090,051 | 1,415,225 |
| Net Income | 525,705 | 714,138 | 908,906 |
| Net Change in Cash | -182,980 | 414,293 | 302,449 |
(* All numbers are in thousands)
Analyst Estimates
| Fiscal Year | 2031 | Research Access | Research Access | Research Access | Research Access |
|---|---|---|---|---|---|
| Estimated Revenue (Low) | 5,704,436.837 | Research Access | Research Access | Research Access | Research Access |
| Estimated Revenue (High) | 5,868,095.042 | Research Access | Research Access | Research Access | Research Access |
| Estimated Revenue (Avg) | 5,775,045 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (Low) | 2,849,205.744 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (High) | 2,954,220.357 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (Avg) | 2,894,513.607 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (Low) | 2,369,792.660 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (High) | 2,458,507.084 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (Avg) | 2,408,067.914 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (Low) | 1,421,872.206 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (High) | 1,462,665.199 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (Avg) | 1,439,471.802 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (Avg) | 14.420 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (High) | 14.720 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (Low) | 14.190 | Research Access | Research Access | Research Access | Research Access |
| Number of Analysts (Estimated Revenue) | 7 | Research Access | Research Access | Research Access | Research Access |
| Number of Analysts (Estimated EPS) | 4 | Research Access | Research Access | Research Access | Research Access |
Log in to continue
Log in and subscribe to Full Access to see up to 5 years of analyst estimates.
Login — it's free(* All numbers are in thousands)
Current Key Metrics
Log in to continue
Log in to see all key valuation metrics and ratios for this symbol.
Login — it's freeForward P/E Ratios
Log in to continue
Log in with Full Access for forward P/E high/low estimates and the full multi-year table.
Login — it's freeSWOT Analysis
Strengths (preview)
- Robust Financial Performance: Veeva Systems reported strong fiscal 2025 fourth quarter and full-year results, with key financial metrics such as revenue, net income, and operating cash flow showing consistent growth as per income and cash flow statements. High gross profit margin (TTM) and net profit margin (TTM) from key metrics indicate efficient operations and profitability.
- Strong Liquidity Position: Balance sheet data highlights significant cash and cash equivalents alongside a favorable current ratio (TTM) and quick ratio (TTM), demonstrating the company’s ability to meet short-term obligations and invest in growth initiatives.
- Industry Leadership and Innovation: As noted in the earnings call transcript, Veeva’s strategic focus on product development and addressing industry-specific challenges in the life sciences sector (per company profile and sector data) positions it as a leader within its niche, supported by a high return on equity (ROE TTM) and return on invested capital (ROIC TTM).
Log in with Research Access for Weaknesses, Opportunities, Threats, and the complete SWOT.
At what price to buy it? -
Intrinsic Value Calculator
Based on current fundamentals and analyst forecasts, MARKETSnap estimates VEEV intrinsic value between $79.67 – $262.10 per share. This depends on revenue growth, margins, and discount rate.
This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.
[intrinsic_calculator]
Common questions about VEEV valuation
Is Veeva Systems Inc. (VEEV) overvalued or undervalued right now?
MARKETSnap estimates intrinsic value for Veeva Systems Inc. (VEEV) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.
Is VEEV a buy, hold, or sell for long-term investors?
MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether VEEV trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.
What is VEEV’s P/E ratio?
You can see VEEV’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.
How is intrinsic value calculated for VEEV?
MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.
Is VEEV a good long-term investment?
Whether VEEV fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.
VEEV
1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.
Daily snapshot
0.54
Trading Metrics:
| Open: | 261.81 | Previous Close: | 260.98 | |
| Day Low: | 259.54 | Day High: | 263.69 | |
| Year Low: | 148.05 | Year High: | 310.5 | |
| Price Avg 50: | 225.24 | Price Avg 200: | 198.47 | |
| Volume: | 863673 | Average Volume: | 2.626M |
Log in to continue
Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.
Login — it's freeVEEV full analysis
Hey everyone, welcome back to the channel! Today, we’re diving deep into a comprehensive analysis of Veeva Systems, ticker VEEV, a major player in the cloud-based software space for the life sciences industry. If you’re looking to understand whether this stock deserves a spot in your portfolio, stick around because we’re covering everything from financials to valuation, recent performance, and much more. Let’s get started! So, what’s the big picture with Veeva Systems? If you’re not familiar, Veeva is a…
